Published in TB and Outbreaks Week, May 8th, 1995
Stanford University researchers described the development of antigen expression systems elicited by recombinant BCG vaccine strains to bacterial and HIV antigens ("Bacterial Vaccine Vectors and Bacillus Calmette-Guerin," Clinical Infectious Diseases, April 1995;20:1011-1009).
Researcher Jeffrey D. Cirillo and colleagues propose a modified recombinant BCG carrier with selection for the stable maintenance of rDNA.
Recent advances in biotechnology now...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week